USE OF A MODIFIED ACTIVATED PARTIAL THROMBOPLASTIN TIME TO DETECT LUPUS ANTICOAGULANTS

By Cloherty T.   Golden E.A.   Lind S.E.  

Thrombosis Research, Vol. 83, Iss. 2, 1996-07 ,pp. : 137-142

Elsevier

Access to resources Recommend Favorite

Mathematical Model for the Blood Coagulation Prothrombin Time Test - Effects of Calcium, Phospholipids, and Tissue Factor

By Khanin M.A.   Rakov D.V.   Kogan A.E.  

Thrombosis Research, Vol. 89, Iss. 5, 1998-03 ,pp. : 227-232

Elsevier

Access to resources Recommend Favorite

EVALUATION OF BEDSIDE PROTHROMBIN TIME AND ACTIVATED PARTIAL THROMBOPLASTIN TIME MEASUREMENT BY COAGULATION ANALYZER COAGUCHECK PLUS ( R) IN VARIOUS CLINICAL SETTINGS

By Ruzicka K.   Kapiotis S.   Quehenberger P.   Handler S.   Hornykewycz S.   Michitsch A.   Huber K.   Clemens D.   Susan M.   Pabinger I.   Eichinger S.   Jilma B.   Speiser W.  

Thrombosis Research, Vol. 87, Iss. 5, 1997-09 ,pp. : 431-440

Elsevier

Access to resources Recommend Favorite

Variations of prothrombin time and international normalized ratio in patients treated with warfarin

By Ho C.-H.   Lin M.-W.   You J.-Y.   Chen C.-C.   Yu T.-J.  

Thrombosis Research, Vol. 107, Iss. 5, 2002-09 ,pp. : 277-280

Elsevier

Access to resources Recommend Favorite

Safety and Efficacy of MRI-Based Selection for Recombinant Tissue Plasminogen Activator Treatment: Responder Analysis of Outcome in the 3-Hour Time Window

By  

Cerebrovascular Diseases, Vol. 27, Iss. 3, 2009-01 ,pp. : 223-229

Karger

Access to resources Recommend Favorite